FDA Inspection 1158795 — AMICUS THERAPEUTICS
The FDA completed an inspection of AMICUS THERAPEUTICS on November 5, 2021 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 5, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)